Literature DB >> 17201045

The art and science of switching of antipsychotic medications, part 1.

Peter J Weiden1, Allan H Young, Peter F Buckley.   

Abstract

In the presentation "Prevalence of and Factors Influencing the Switching of Antipsychotic Medications," Weiden defines the recovery approach for the treatment of schizophrenia, focuses on reasons for switching antipsychotic medications, and offers recommendations for evaluating switch studies. In "Combining and Switching Medications in Bipolar Disorder," Young discusses the similarities and differences between schizophrenia and bipolar disorder, offers recommendations for switching medications in bipolar disorder, and evaluates studies of atypical antipsychotics in the treatment of bipolar disorder. Buckley's presentation, "Differential Pharmacology of Atypical Antipsychotics: Clinical Implications," examines response rates in patients with schizophrenia after switching antipsychotic medications, outlines receptor-binding profiles of atypical antipsychotics, highlights adverse events that may occur when switching antipsychotic medications, and offers recommendations for treating those adverse events.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17201045     DOI: 10.4088/jcp.1106e15

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  2 in total

1.  Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in schizophrenia.

Authors:  Pilar Cazorla; Mary Mackle; Jun Zhao; Xianwei Ha; Armin Szegedi
Journal:  Neuropsychiatr Dis Treat       Date:  2012-06-15       Impact factor: 2.570

2.  Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response-a prospective open-label study.

Authors:  Naoki Hashimoto; Atsuhito Toyomaki; Minoru Honda; Satoru Miyano; Nobuyuki Nitta; Hiroyuki Sawayama; Yasufumi Sugawara; Keiichi Uemura; Noriko Tsukamoto; Tsukasa Koyama; Ichiro Kusumi
Journal:  Ann Gen Psychiatry       Date:  2015-01-22       Impact factor: 3.455

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.